sb 203580 has been researched along with dihydroresveratrol in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (dihydroresveratrol) | Trials (dihydroresveratrol) | Recent Studies (post-2010) (dihydroresveratrol) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 35 | 2 | 27 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burton, DG; Davis, T; Faragher, RG; Fong, NS; Majecha, P; Ostler, EL; Sheerin, A | 1 |
1 other study(ies) available for sb 203580 and dihydroresveratrol
| Article | Year |
|---|---|
Resveratrol, but not dihydroresveratrol, induces premature senescence in primary human fibroblasts.
Topics: beta-Galactosidase; Cell Line; Cell Proliferation; Cells, Cultured; Cellular Senescence; Dose-Response Relationship, Drug; Fibroblasts; Humans; Imidazoles; Ki-67 Antigen; p38 Mitogen-Activated Protein Kinases; Pyridines; Resveratrol; Stilbenes | 2011 |